protein
| binding to the death effector domain of caspase-8 and to FADD |
|
associating with nuclear protein, ataxia-telangiectasia, a component of the cell-cycle-dependent histone gene transcription machinery |
|
interacting with histone gene promoter sequences |
|
MYB-interacting protein (interacts with the DNA-binding domain of MYB and enhances MYB-dependent reporter activity and expression of endogenous MYB target genes)  |
|
MYB cooperates with CASP8AP2 in foci associated with active POLR2A, leading to enhancement of MYB-dependent gene activation  |
|
links the CD95 signaling pathway to the cell nucleus and nuclear bodies  |
|
interaction between CASP8AP2 and SRRT are required for S phase progression(CASP8AP2 functions in S phase progression through interaction with SRRT)  |
|
interacting with CPSF3 (catalyses the 3prime-end cleavage of histone pre-mRNAs, requiring the interaction of two U7 snRNP-associated proteins, CASP8AP2 and LSM11)  |
|
PIAS1 is a common partner for two cancer-related nuclear factors, MYB and CASP8AP2 (functional cooperation between CASP8AP2 and PIAS1 in the enhancement of MYB activity in active nuclear foci)  |
|
TP73 binds to CASP8AP2 and is part of the complex that regulates histone gene transcription  |
|
SUMO targets CASP8AP2 for proteasome-dependent degradation, which is associated with recruitment of CASP8AP2 to PML bodies  |